1. Home
  2. BDSX vs CATO Comparison

BDSX vs CATO Comparison

Compare BDSX & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

BUY

Current Price

$15.77

Market Cap

122.0M

Sector

Health Care

ML Signal

BUY

Logo Cato Corporation (The)

CATO

Cato Corporation (The)

HOLD

Current Price

$2.89

Market Cap

59.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
CATO
Founded
2005
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
122.0M
59.8M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
BDSX
CATO
Price
$15.77
$2.89
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
127.3K
43.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.09
EPS
N/A
0.25
Revenue
$88,499,000.00
$649,806,000.00
Revenue This Year
$22.01
N/A
Revenue Next Year
$26.81
N/A
P/E Ratio
N/A
$12.00
Revenue Growth
24.08
N/A
52 Week Low
$0.25
$2.19
52 Week High
$17.40
$4.92

Technical Indicators

Market Signals
Indicator
BDSX
CATO
Relative Strength Index (RSI) 73.20 41.95
Support Level $6.33 $2.80
Resistance Level N/A $3.22
Average True Range (ATR) 1.71 0.17
MACD 0.29 0.00
Stochastic Oscillator 74.31 41.56

Price Performance

Historical Comparison
BDSX
CATO

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

Share on Social Networks: